Sign In
Buy MBOT
$1.72
-0.0200 (-1.15%)
At Close: Jul 31, 2026
Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 Completion of enrollment expected in Q4 with FDA submission for commercialization antic
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY
01:01pm, Friday, 23'rd Aug 2024
Microbot Medical (MBOT) signs a Phase 2 collaboration agreement with Corewell Health to advance remote telesurgery for endovascular procedures using LIBERTY.
The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform
Microbot Medical (MBOT) Gets Quality Certification for its System
12:05pm, Monday, 19'th Aug 2024
Microbot Medical (MBOT) secures ISO 13485:2016 certification for its LIBERTY Endovascular Robotic System, a milestone that streamlines European and FDA regulatory compliance for future commercializati
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
08:30am, Tuesday, 13'th Aug 2024
The ISO 13485 certification is a validation of the Company's robust quality system The ISO 13485 certification is a validation of the Company's robust quality system
Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics
12:30pm, Monday, 05'th Aug 2024
Microbot Medical (MBOT) announces an agreement with Emory University to explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system.
The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system The evaluation phase will explore the potential of integratin
As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women's Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial As the third and
Microbot Medical (MBOT) Progresses in Its Human Clinical Trial
02:51pm, Thursday, 11'th Jul 2024
Microbot Medical's (MBOT) latest patient enrollment in its pivotal human clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY system.
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
08:30am, Tuesday, 09'th Jul 2024
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company's Pivotal Human Clinical Trial.
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
08:20am, Monday, 08'th Jul 2024
The first clinical case was performed at Brigham and Women's Hospital The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascula
Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial
12:51pm, Friday, 05'th Jul 2024
Microbot Medical's (MBOT) LIBERTY Endovascular Robotic System trial expands to Baptist Hospital of Miami, promising advancements in clinical outcomes and endovascular procedures.
Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY
02:50pm, Thursday, 04'th Jul 2024
Microbot (MBOT) signs a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System as a part of its Investigational Device Exemption.
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
08:20am, Wednesday, 03'rd Jul 2024
Following the Company's recent FDA approval to commence its pivotal human clinical trial, Baptist Hospital of Miami is the second clinical site to enroll in the trial Following the Company's recent FD
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
08:25am, Thursday, 20'th Jun 2024
Following FDA Approval to Commence the Clinical Trial, an Official Site Initiation Has Taken Place as Preparation for Patient Enrollment Advances
